Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient
Executive Summary
Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.
You may also be interested in...
CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts
Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.
US Wellness Market In 2019: Farm Bill Made Cultivating Cannabidiol Policy FDA's Main Course In Supplements
As HBW Insight looks back on notable US wellness market developments and events for the previous 12 months, we find that news in the CBD space from the FDA and the industry dominated the sector throughout 2019.
Senate FDA Appropriation Includes $2M For CBD Enforcement Discretion Policy
Instruction in Appropriations Committee report on FY 2020 spending bill garners support from some stakeholders while others say setting a safe level of CBD's use in non-drug products should come first. Senate appropriators endorses FDA policy that regulations allowing sales of CBD non-drug products "not discourage the development of new drugs."
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
